Committee for Orphan Medicinal Products (COMP): 4-6 December 2018

Date:
04/12/2018 to 06/12/2018
Location: European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

How useful was this page?

Add your rating